Intra-Cellular Therapies (ITCI) trading halted with news pending
- Target (TGT) November/December Comps Fell 1.3%; Lowers Guidance
- US Drone Market Could Reach 6 Million By 2019 - Oppenheimer
- Eli Lilly (LLY) to Acquire CoLucid Pharmaceuticals (CLCD) for $960M
- The FTC Confirms Antitrust Charges Against Qualcomm (QCOM) for Monopolizing Semiconductor Device Used in Cell Phones
- United Airlines (UAL) Tops Q4 EPS by 5c
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Intra-Cellular Therapies (NASDAQ: ITCI) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pulmatrix (PULM) Halted on LUDP, Shares Up 105%
- Pulmatrix (PULM) Halted on LUDP
- Alcobra Ltd. (ADHD) Halted, News Pending
Create E-mail Alert Related CategoriesTrading Halts
Related EntitiesThe Children's Investment Fund (TCI)
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!